Alnylam Pharmaceuticals, Inc.
ALNYBioteknologiTutup
228.06+1.8%Leverage nganti 1000xDagang ALNY
Apa sing dilaporake
Dilaporake tanggal 2026-07-30, 88 dina kepungkur.
Prakiraan lan asil nyata
| Prakiraan | Nyata | Kejutan | |
|---|---|---|---|
| Pemasukan | 1.3B | 1.3B+66.9% taun-ing-taun | -2.4% |
| Bathi bersih | 225.4M | 164.5M+348.2% taun-ing-taun | -27.0% |
| Bathi saben saham | 1.63 | 1.21+337.3% taun-ing-taun | -25.8% |
Pambandhing taun-ing-taun nganggo kuartal sing padha taun kepungkur (2025-07-31), dudu kuartal sadurunge.
ALNY didol tuku ing kene kanthi leverage nganti 1000x. Ing 1000x, obah 0.10% sing nglawan sampeyan bakal ngentekake kabeh margin. Iki durung ngetung fee, funding, lan maintenance margin, sing kabeh mau bakal nyepetake liquidation. Rega liquidation sampeyan sing sejatine yaiku sing ditampilake ing kaca order.
Ing kene sampeyan bisa nahan posisi nglewati wektu pengumuman
ALNY diaji ing kene 24 jam sedina lan ora mandheg nalika pasar AS tutup. Ing bursa AS, kabar sing padha mung katon minangka gap ing bukaan sabanjure.
Sing dikarepake pasar
Kanggo kuartal sing rampung ing 2026-09-30.
Dibandhingake karo kuartal sing padha taun kepungkur (2025-10-30): EPS -9.8%pendhapatan +14.5%
Iki prakiraan saka analis pihak katelu. CoinUnited.io ora nggawe lan ora milih analis sing dilebokake.
Asal-usul pendhapatan
- Product91.5%1.2B
- GIVLAARI7%89.8M
- ONPATTRO1.4%18.5M
Kuartal paling anyar sing dilaporake (2026-06-30).
Rekam Jejak
Laporan sabanjure dikira 2026-10-29. Nglaporake quarterly.
Ngungkuli estimasi ing 5 saka 8 kuartal pungkasan. Selisih sing lumrah yaiku +0.04 saben saham.
Sepira gedhene pageseran sing nyata
±3.1%
Pageseran median ing rong sesi sakiwa-tengene laporan, saka 8 asil pungkasan. Ing rong dina biasa, pageserane 1.8%.
2026-07-30-28.95%
2024-10-31Pageran sajrone rong sesi ing sakubenge saben laporan2026-07-30
Ngungkuli utawa kurang, banjur munggah utawa mudhun
| Munggah | Mudhun | |
|---|---|---|
| Ngungkuli | 1 | 4 |
| Kurang | 0 | 3 |
Diitung saka 8 asil. Iki sing wis kedadeyan, dudu sing bakal kedadeyan.
Prakiraan analis kanggo 12 sasi ngarep
Rentang wektu iki beda karo bagean liyane ing kaca iki: iki tampilan 12 sasi, dudu pergerakan rong dina ing sakubenge laporan.
| Institusi | Sasaran | Tanggal | Sumber |
|---|---|---|---|
| UBS | 354.00 | 2026-10-15 | TheFly |
| Wells Fargo | 253.00 | 2026-10-14 | TheFly |
| RBC Capital | 345.00 | 2026-10-08 | TheFly |
| Jefferies | 260.00 | 2026-09-08 | TheFly |
| Bernstein | 376.00 | 2026-08-25 | StreetInsider |
| BMO Capital | 318.00 | 2026-08-18 | TheFly |
| H.C. Wainwright | 455.00 | 2026-08-04 | TheFly |
| Truist Financial | 315.00 | 2026-08-04 | TheFly |
| Barclays | 450.00 | 2026-08-03 | TheFly |
| Raymond James | 420.00 | 2026-07-31 | TheFly |
| Oppenheimer | 350.00 | 2026-07-31 | TheFly |
| Morgan Stanley | 300.00 | 2026-07-31 | TheFly |
| Stifel Nicolaus | 318.00 | 2026-07-31 | TheFly |
Data saka 13 institusi sing ngumumake target rega sajrone 180 dina kepungkur, nganggo prakiraan paling anyar saben institusi. Target rega ditemtokake dening institusi kasebut; CoinUnited.io ora nggawe utawa ndhukung.
Asil Laporan
| Dilaporake | EPS estimasi | EPS aktual | Kejutan | Kejutan Pendapatan |
|---|---|---|---|---|
| 2026-07-30 | 1.63 | 1.21 | -25.8% | -2.4% |
| 2026-04-30 | 0.872 | 1.51 | +73.2% | +4.6% |
| 2026-02-12 | 1.16 | 0.82 | -29.3% | -4.5% |
| 2025-10-30 | 0.561 | 1.84 | +228.0% | +30.2% |
| 2025-07-31 | -0.5437 | -0.51 | +6.2% | +16.7% |
| 2025-05-01 | -0.89 | -0.44 | +50.6% | +1.5% |
| 2025-02-13 | -0.62 | -0.65 | -4.8% | +1.8% |
| 2024-10-31 | -0.9166 | -0.87 | +5.1% | -6.0% |
| 2024-08-01 | -1.07 | -0.13 | +87.9% | +47.5% |
| 2024-05-02 | -1.12 | -0.52 | +53.6% | +15.5% |
| 2024-02-15 | -1.2 | -1.1 | +8.3% | +0.6% |
| 2023-11-02 | -1.34 | 1.15 | +185.8% | +89.2% |
Uga nglaporake sajrone rong minggu iki ing Bioteknologi
INSM 
MRNA 
REGN 
ROIV 
RVMD 
TECH 2 liyane ing Bioteknologi
Riwayat EPS kanggo ALNY wiwit 2003-03-31 nganti 2026-07-30, 90 laporan.Riwayat reaksi nyakup 8 asil pungkasan, sing dadi wates jeroning data rega harian dhasar kita.